Buys
Open market- Shares
- +74,335
- Avg price
- $11.53
- Total value
- +$856,794
Panacea Innovation Ltd - 10%+ Owner at Atara Biotherapeutics, Inc.
Issuer-level insider activity
- Role
- 10%+ Owner
- Issuer ticker
- ATRA on Nasdaq
- Entity type
- Company
- Source filing history
- Open source filing history
Identity
Names, identifiers, and filing context for this profile.
1 identity field
Source evidence
Original filing metadata and source links for verification.
1 source field
Past-year transaction volume for Panacea Innovation Ltd in Atara Biotherapeutics, Inc.
Sells
Open market- Shares
- -313,446
- Avg price
- $10.10
- Total value
- -$3,165,021
Net
Past year- Shares
- -239,111
- Share %
- -62%
- Total value
- -$2,308,226
Reported holdings for Panacea Innovation Ltd in Atara Biotherapeutics, Inc.
Form 4 holding
Director, 10%+ Owner
Atara Biotherapeutics, Inc.
- Security class
- Common Stock
- Shares / value
- 1,011,000
- Estimated value
- $10,208,572
- Report date
- 07 May 2026
- Price
- $10.10
- Ownership
- Indirect
Form 4 holding
10%+ Owner
Atara Biotherapeutics, Inc.
- Security class
- Common Stock
- Shares / value
- 1,011,000
- Estimated value
- $10,208,572
- Report date
- 07 May 2026
- Price
- $10.10
- Ownership
- Indirect
Form 4 holding
10%+ Owner
Atara Biotherapeutics, Inc.
- Security class
- Warrants
- Shares / value
- 0
- Estimated value
- $1,713,041
- Report date
- 17 Mar 2026
- Price
- $6.61
- Ownership
- Indirect
- Underlying class
- Common Stock
- Underlying amount
Transaction history for Panacea Innovation Ltd in Atara Biotherapeutics, Inc.
| Sym | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares after | Date | Ownership |
|---|
* marks a reported price that did not pass the local price check.